This paper takes a look at the current CNS market and explores five trends that will help drive it during 2026 and beyond:

  1. Merger and acquisition (M&A) and dealmaking trends
  2. Key Alzheimer’s developments
  3. Blood-brain barrier (BBB) shuttle technology as the “next frontier”
  4. Notable failures changing how we think about targets and pathways
  5. Notable advances that may lead to therapeutic innovation